Smart Pills Drug Delivery Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 4.37 Billion |
| Market Size (2029) | USD 7.24 Billion |
| CAGR (2024 - 2029) | 10.61 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Smart Pills Drug Delivery Market Analysis
The Smart Pills Drug Delivery Market size is estimated at USD 4.37 billion in 2024, and is expected to reach USD 7.24 billion by 2029, growing at a CAGR of 10.61% during the forecast period (2024-2029).
The COVID-19 pandemic has boosted the demand for smart pills for managing patients suffering from COVID-19 and other associated disorders. It has also fueled the research and development activities for developing smart drugs. For instance, as per an article published by the International Journal on Emerging Technologies, in August 2020, in times of the COVID-19 pandemic, there was a need to develop a pill drug delivery system with a preprogrammed feature that will be used by the elderly or infected people. The proposed preprogrammed pill dispenser (PPD) is one such approach that is designed to help them to take their medicines at regular intervals of time. It states that the proposed preprogrammed drug delivery system is designed with an alerting module using an alarm and camera unit, which is one such approach intended to help patients take their medications at regular intervals as the in-home medical care cost in a developing country is much higher, which leads the individual to think of a cost-effective solution. Hence, with the abovementioned factors, it is observed that the market studied was positively impacted.
Specific factors driving the smart pills drug delivery market growth include increasing preference for minimally invasive devices, increasing incidence of gastrointestinal disorders, and technological advancements. Additionally, the increasing burden of neurological, cancer and other diseases drives the demand for intelligent pills in healthcare settings. For instance, according to the World Health Organization September 2021 update, around 55 million people have dementia, with over 60% living in low and middle-income countries. The same source also reports that this number is expected to rise to 78 million in 2030 and 139 million in 2050. With the increasing cases of Alzheimer's and dementia, there are increased chances of missing doses of medication or wrong administration of it, increasing the need for smart pills and drug delivery. Thus, the increasing burden of diseases around the globe and the need for care drives the market studied.
According to an article published by GIE Media, Inc., in December 2021, the need to perform highly skilled actions using specialized tools with limited visibility and motion range has introduced higher levels of expertise for surgical teams. Support equipment includes endoscopic cameras, visualization scanners, contrast injectors, etc. According to an article published on JAMA Network in January 2020, most surgeons currently opt for advanced minimally invasive surgical procedures such as laparo-endo single-incision surgery (LESS) due to their advantages over traditional open surgical techniques. These advantages include fewer scars and tissue injury, quicker recovery periods, shorter hospital stays, reduced blood loss and trauma, lower risk of infection, and reduced overall healthcare costs. In addition, minimally invasive surgeries are increasingly being covered by health insurance providers in selected countries. These factors have led to an increased preference for minimally invasive surgeries among patients leading to the growth of the smart pills drug delivery market.
Therefore, the abovementioned factors are attributed collectively to the studied market growth over the forecast period. However, stringent regulations for approving smart pills and potential health risks are expected to hinder market growth over the forecast period.
Smart Pills Drug Delivery Market Trends
Capsule Endoscopy is Expected to Hold Significant Market Share in the Type Segment
Capsule endoscopy is a procedure that uses a tiny wireless camera to take pictures of your digestive tract. A capsule endoscopy camera sits inside a vitamin-size capsule you swallow. As the capsule travels through your digestive tract, the camera takes thousands of pictures transmitted to a recorder you wear on a belt around your waist. With the advent of healthcare technology, smart pills can eliminate the need for invasive procedures. Various advances are being undertaken in smart drugs, such as batteries and onboard memory, making them significant for long-term usage. According to an article published by Gastroenterology & Endoscopy News in March 2022, capsule endoscopy has a high positive (94%-97%) and negative (83%-100%) predictive value in the evaluation of GI bleeding, and findings on capsule endoscopy can lead to endoscopic or surgical intervention or a change in medical management in 37% to 87% of patients. Hence, with the continuous advancements that are being made in the area of endoscopy, and with the rising in gastrointestinal disorders (GI) and the need for proper diagnosis, it is believed that the market studied will have rapid growth over the forecast period.
The segment is expected to witness healthy growth due to the global companies inclining toward the smart capsule. For instance, Medtronic provides PillCam SB1 and PillCam SB2, Olympus provides Endocapsule and Endocapsule 10, NaviCam Stomach is developed by Ankon, whereas, CapsoVision provides CapsoCam in the global markets. Advanced technologies and product approvals in the market are also expected to drive segment growth. For instance, In November 2021, Medtronic plc announced the United States Food and Drug Administration (FDA) clearance for its PillCam Small Bowel 3 system for remote endoscopy procedures. Additionally, in July 2022, Scottish health researchers launched a new EUR 6 million project to make Artificial Intelligence-assisted (AI) capsule endoscopy a part of future bowel cancer diagnostics. Clinical Capsule Endoscopy (CCE) utilizes a 'smart pill' containing cameras that, once swallowed by a patient, records images of the intestines as it passes through.
Therefore, the factors mentioned above are expected to drive segmental growth in the market during the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America has dominated the global market studied, owing to the factors, such as the wide acceptance of technologically advanced solutions to make patient care hassle-free, a large pool of customers, and a rapidly growing geriatric population.
A growing number of medication errors due to human intervention in specialty drug delivery may result in steep upward growth, which requires the need to focus on providing value-based care to patients in the United States. As per an article published by the National Library of Medicine, in July 2022, 7,000 to 9,000 persons each year in the United States alone die as a result of drug mistakes. Additionally, millions of additional people have adverse reactions or other pharmaceutical issues but frequently fail to disclose them. According to the United States Food and Drug Administration (FDA), in 2020, it was found that every year more than 100,000 cases of suspected medication errors are reported in the United States. Thus, the statistics indicate that there has been a rising need for smart pill products in the country to avoid medication errors.
As per the 2022 Alzheimer's Disease facts and figures report, more than 6 million Americans of all ages have Alzheimer's and an estimated 6.5 million Americans aged 65 and older are living with Alzheimer's in 2022. The same source reports that out of the total US population, about 1 in 9 people (10.7%) age 65 and older has Alzheimer's dementia and the percentage of people with Alzheimer's dementia increases with age, 5.0% of people aged 65 to 74. Thus, the statistics indicate that the demand for smart pills is expected to rise in the United States.
Smart Pills Drug Delivery Industry Overview
The Smart Pills Drug Delivery market is consolidated due to the presence of several companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known, including CapsoVision, Check-Cap, etectRx Inc., HQ Inc., Jinshan Science and Technology, Koninklijke Philips NV (Medimetrics), Medtronic PLC, Olympus Medical Technology, Otsuka Pharmaceutical Co. Ltd, Proteus Pharmaceuticals, and Intromedic, among others.
Smart Pills Drug Delivery Market Leaders
-
Check-Cap
-
etectRx Inc.
-
CapsoVision
-
Otsuka Pharmaceutical Co. Ltd
-
HQ Inc.
*Disclaimer: Major Players sorted in no particular order
Smart Pills Drug Delivery Market News
- In March 2022, AccelmedPartners, a private equity firm focused on acquiring and investing in the US commercial stage, lower middle market HealthTechcompanies, reported that it led a USD 40 million investment in MedMinder Systems Inc., the leading fully-integrated, end-to-end pharmacy, medication adherence, and connected care solution for elderly and polypharmacy patients.
- In March 2022, iZafeGroup reported that the partner RemedioSRL is ready with its pilot of Dosell, which will be included in its concept of Sempli Farmland. An initial order for 50 Dosellwill is sent to Italy.
- In January 2022, Novo Nordisk launched the anti-diabetes pill semaglutide in India, which can treat type 2 diabetes. Semaglutide is a glucagon-like peptide (GLP-1) receptor analog molecule which has become promising addition to diabetes treatment.
Smart Pills Drug Delivery Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Preference for Minimally Invasive Devices
4.2.2 Increasing Incidence of Chronic Disorders
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 Stringent Regulations for the Approval of Smart Pills
4.3.2 Potential Health Risk
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION ( Market size by Value in USD)
5.1 Type
5.1.1 Capsule Endoscopy
5.1.2 Patient Monitoring
5.1.3 Drug and Delivery Systems
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East and Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East and Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 CapsoVision
6.1.2 Check-Cap
6.1.3 etectRx Inc.
6.1.4 HQ Inc.
6.1.5 Jinshan Science and Technology
6.1.6 Koninklijke Philips NV (Medimetrics)
6.1.7 Medtronic PLC
6.1.8 Olympus Medical Technology
6.1.9 Otsuka Pharmaceutical Co. Ltd
6.1.10 Intromedic
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Smart Pills Drug Delivery Industry Segmentation
As per the scope of the report, smart pills are capsules prescribed to patients and are equipped with electronic sensors, which send a wireless message to devices, like patches, tablets, or smartphones, outside the body when they are ingested. The Smart Pills Drug Delivery Market is segmented by Type (Capsule Endoscopy, Patient Monitoring, and Drug and Delivery Systems) and Geography (North America, Europe, Asia-Pacific, Middle East, Africa, and South Amerie market report also covers the estimated market sizes and ten different countries across significant regions globally. The report offers the value (in USD million) for the above segments.
| Type | |
| Capsule Endoscopy | |
| Patient Monitoring | |
| Drug and Delivery Systems |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Smart Pills Drug Delivery Market Research FAQs
How big is the Smart Pills Drug Delivery Market?
The Smart Pills Drug Delivery Market size is expected to reach USD 4.37 billion in 2024 and grow at a CAGR of 10.61% to reach USD 7.24 billion by 2029.
What is the current Smart Pills Drug Delivery Market size?
In 2024, the Smart Pills Drug Delivery Market size is expected to reach USD 4.37 billion.
Who are the key players in Smart Pills Drug Delivery Market?
Check-Cap, etectRx Inc., CapsoVision, Otsuka Pharmaceutical Co. Ltd and HQ Inc. are the major companies operating in the Smart Pills Drug Delivery Market.
Which is the fastest growing region in Smart Pills Drug Delivery Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Smart Pills Drug Delivery Market?
In 2024, the North America accounts for the largest market share in Smart Pills Drug Delivery Market.
What years does this Smart Pills Drug Delivery Market cover, and what was the market size in 2023?
In 2023, the Smart Pills Drug Delivery Market size was estimated at USD 3.91 billion. The report covers the Smart Pills Drug Delivery Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Smart Pills Drug Delivery Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Smart Pills Drug Delivery Industry Report
Statistics for the 2024 Smart Pills Drug Delivery market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Smart Pills Drug Delivery analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
